• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE, INC. NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE, INC. NEUROPACE RNS SYSTEM Back to Search Results
Model Number RNS-300M-K
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Erosion (1750)
Event Date 02/19/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).This is the patient's third neurostimulator implanted on (b)(6) 2016.Patient is implanted with a cortical strip lead (port 1, sn (b)(4)) and depth lead (port 2, sn (b)(4)).Continued use.
 
Event Description
The patient called the neuropace representative stating that he scratched his head resulting in the scab coming off and the hardware is now visible.The fce instructed him to go to the (b)(6) er for treatment.Details from the study site coordinator - the patient called the site coordinator to report that on the morning of (b)(6) 2017 he woke up with a hole in his head and brain fluid all over.He called the number on his neuropace wallet card and was referred to the medical university of (b)(6).The patient did not see any blood coming from the open area.The patient was evaluated by the neurosurgery team who observed yellow clear fluid that appears to be csf leaking from open wound on top of scalp; wires (leads) were visible in a picture taken by the patient.The patient was admitted for washout, closure, and skin repair with long-term suppressive antibiotics.Skull skin flap elevated and intracranial electrodes were mobilized from the erosion.Active problems at discharge: infection of brain stimulator.Exposure of implanted material to surrounding tissue.Ct head - small bilateral meningoceles seen along previously resected zygomatic segments of temporal bone.Treated with three days of iv vancomycin.Discharged on oral bactrim but after culture changed to penicillin vk 1000 mg three times daily for 10 days on (b)(6) 2017.On (b)(6) 2017 it was decided to readmit subject for placement of picc line and longer term course of iv antibiotics.The rns system remains implanted.The rns system is currently programmed for detection and treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave.
mountain view, CA 94043
6502382788
MDR Report Key6417300
MDR Text Key70339803
Report Number3004426659-2017-00012
Device Sequence Number1
Product Code PFN
UDI-Device Identifier00855547005120
UDI-Public010085554700512017160526
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/20/2017
Is this an Adverse Event Report? Yes
Device Operator Device Unattended
Device Model NumberRNS-300M-K
Device Catalogue Number1007603
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/19/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age38 YR
-
-